Newsfeeds - Spark Newswire

1 minute read

Lantronix Q3 Adj. EPS $0.08 Beats $0.07 Estimate, Sales $32.30M Beat $29.48M Estimate

Today, 9:18 AM

Lantronix (NASDAQ:LTRX) reported quarterly earnings of $0.08 per share which beat the analyst consensus estimate of $0.07 by 14.29 percent. This is a 60 percent increase over earnings of $0.05 per share from the same

LTRX

27 minute read

Earnings Scheduled For May 4, 2022

By Benzinga Insights

Today, 9:18 AM

Companies Reporting Before The Bell • Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.

ABC

4 minute read

55 Biggest Movers From Friday

By Lisa Levin

Today, 9:18 AM

Gainers Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares jumped 100.9% to close at $2.27 on Friday. Vallon Pharmaceuticals engaged Ladenburg Thalmann & Co Inc to evaluate strategic alternatives for the Company to maximize shareholder value.

ALVR

1 minute read

Canaccord Genuity Initiates Coverage On Lantronix with Buy Rating, Announces Price Target of $13

By Benzinga Newsdesk

Today, 9:18 AM

Canaccord Genuity analyst Michael Walkley initiates coverage on Lantronix (NASDAQ:LTRX) with a Buy rating and announces Price Target of $13.

LTRX

11 minute read

Earnings Scheduled For February 10, 2022

By Benzinga Insights

Today, 9:18 AM

Companies Reporting Before The Bell • Canada Goose Hldgs (NYSE:GOOS) is projected to report quarterly earnings at $1.46 per share on revenue of $584.49 million.

ACB

5 minute read

54 Biggest Movers From Yesterday

By Lisa Levin

Today, 9:18 AM

Gainers Longeveron Inc. (NASDAQ: LGVN) shares climbed 135.3% to close at $6.87 on Thursday. Longeveron said the FDA granted rare pediatric disease designation for the company’s Lomecel-B for the treatment of hypoplastic left heart syndrome.

AEHR

2 minute read

12 Information Technology Stocks Moving In Thursday’s Intraday Session

By Benzinga Insights

Today, 9:18 AM

ALPP

4 minute read

44 Stocks Moving In Thursday’s Mid-Day Session

By Lisa Levin

Today, 9:18 AM

Gainers Longeveron Inc. (NASDAQ: LGVN) jumped 157% to $7.51. Longeveron said the FDA granted rare pediatric disease designation for the company’s Lomecel-B for the treatment of hypoplastic left heart syndrome.

AEHR

2 minute read

12 Information Technology Stocks Moving In Thursday’s Pre-Market Session

By Benzinga Insights

Today, 9:18 AM

ARQQ

2 minute read

Movers

12 Information Technology Stocks Moving In Wednesday’s After-Market Session

By Benzinga Insights

Today, 9:18 AM

Gainers Net 1 UEPS Technologies (NASDAQ:UEPS) stock rose 10.47% to $5.8 during Wednesday's after-market session. The company's market cap stands at $330.5 million.

ASYS